BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2020 11:49:18 AM | Browse: 1137 | Download: 1918
 |
Received |
|
2019-11-08 02:13 |
|
Peer-Review Started |
|
2019-11-08 02:15 |
|
First Decision by Editorial Office Director |
|
2019-12-23 17:57 |
|
Return for Revision |
|
2019-12-23 17:57 |
|
Revised |
|
2020-01-01 19:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-01-09 09:17 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-01-11 14:10 |
|
Articles in Press |
|
2020-01-11 14:10 |
|
Edit the Manuscript by Language Editor |
|
2020-02-03 05:47 |
|
Typeset the Manuscript |
|
2020-02-11 07:55 |
|
Publish the Manuscript Online |
|
2020-02-14 11:49 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yun-Gang Luo, Li-Wei Duan, Xuan Ji, Wen-Yuan Jia, Yun Liu, Mao-Lei Sun and Guo-Min Liu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guo-Min Liu, PhD, Director, Director, Jilin Provincial Medicine Anti-Tumor Engineering Center, The Second Hospital of Jilin University, No. 218, Ziqiang Street, Changchun 130041, Jilin Province, China. lgm@mail.jlu.edu.cn |
| Key Words |
The Cancer Genome Atlas; Bioinformatics analysis; Diagnosis; Prognosis; Recurrence; miR-1304 |
| Core Tip |
In recent years, the morbidity and mortality of esophageal carcinoma have increased significantly. However, there are few clinical tumor markers related to esophageal carcinoma. miRNA is a hot research direction in recent years. This study analyzed the expression of miR-1304 in patients with esophageal carcinoma, and found that miR-1304 was highly expressed in them, and was an independent factor for recurrence and prognosis of esophageal carcinoma. miR-1304 was expected to become a potential index for predicting prognosis and recurrence of esophageal carcinoma. |
| Publish Date |
2020-02-14 11:49 |
| Citation |
Luo YG, Duan LW, Ji X, Jia WY, Liu Y, Sun ML, Liu GM. Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence. World J Gastroenterol 2020; 26(6): 670-685 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i6/670.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i6.670 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
